ResearcherUniversity of PittsburghNo recent work listed

Man‐Tzu Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5005765102. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. Co-author DOI 10.1038/s41467-019-11044-9 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jeremy M. Sharib · 1 shared paper, 2019 · strength 0.11
- Paper Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. DOI 10.1038/s41467-019-11044-9 ↗
Eric Andrew Collisson · 1 shared paper, 2019 · strength 0.11
- Paper Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. DOI 10.1038/s41467-019-11044-9 ↗
Sung Eun Kim · 1 shared paper, 2019 · strength 0.11
- Paper Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. DOI 10.1038/s41467-019-11044-9 ↗
Frank Patrick Mccormick · 1 shared paper, 2019 · strength 0.11
- Paper Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. DOI 10.1038/s41467-019-11044-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.